Azimafoussé Assogba Géoffroy Frank, Jezewski-Serra Delphine, Lastier Dimitri, Quintin Cécile, Denis Bernard, Beltzer Nathalie, Duport Nicolas
Department of Chronic Diseases and Injuries, French Institute for Public Health Surveillance, Saint-Maurice, France.
Department of Chronic Diseases and Injuries, French Institute for Public Health Surveillance, Saint-Maurice, France.
Cancer Epidemiol. 2015 Dec;39(6):964-71. doi: 10.1016/j.canep.2015.09.008. Epub 2015 Nov 9.
The anatomic distribution of advanced colorectal neoplasia is increasingly important for choosing screening strategies and treatment options. We sought to evaluate the impact of repeated screening on the positive predictive value (PPV) for advanced colorectal neoplasia (advanced adenoma, AA, and colorectal cancer, CRC) and their distribution according to anatomic subsite distribution in average-risk adults.
The study included 98,031 men and women aged 50-74 who had a positive g-FOBT in 2010 and 2011 and underwent total colonoscopy. The PPV for detection of AA and CRC and the relative risks were determined with log-binomial models, and the distribution of anatomic subsites was estimated according to screening history.
The median age was 61 years (62 years for participants with AA and 64 for those with CRC). The PPV for detection of advanced neoplasia was 24.5%, substantially higher in men than women (30.7% vs 17.7%), and it increased with age. It also fell at all screening episodes after the first. Subsequent screening episodes were associated with an increased RR for proximal AA (RR 1.13, 95% CI 1.16-1.20). Advancing age (RR 1.28, 95% CI 1.19-1.39 for every 10-year increase in age), female gender (RR 1.31, 95% CI 1.19-1.44), and subsequent screening (RR 1.15, 95% CI 1.04-1.27) were significantly and independently associated with detection of proximal adenocarcinoma. The latter was also detected at an advanced stage more often (RR, 1.24, 95% CI: 1.09-1.42). Early stages of invasive adenocarcinoma (stages I and II) was more likely to be detected in a subsequent than an initial screening (RR 1.07, 95% CI 1.01-1.13).
This study found that subsequent screening episodes using g-FOBT were associated with an increase in the detection rate of proximal AA and CRC, especially among women. The more frequent detection of proximal invasive adenocarcinoma at an advanced stage in subsequent screenings suggests that some of these tumors may well not be real incident lesions, but are likely to include lesions that were missed on the previous screens. Although modest, the increase in the rate of detection of invasive adenocarcinoma at early (and more curable) stages from the first to subsequent screenings, together with this potential for missed diagnoses on initial screening and the increased detection rate for proximal or rectal AA in subsequent screening episodes, underlines the need to reinforce the population's awareness of the importance of regular consistent screening, after negative results.
晚期结直肠肿瘤的解剖分布对于选择筛查策略和治疗方案愈发重要。我们试图评估重复筛查对晚期结直肠肿瘤(高级别腺瘤,AA,和结直肠癌,CRC)阳性预测值(PPV)的影响,以及其在平均风险成年人中根据解剖亚部位分布的情况。
该研究纳入了98031名年龄在50 - 74岁之间的男性和女性,他们在2010年和2011年粪便免疫化学试验(g - FOBT)呈阳性,并接受了全结肠镜检查。使用对数二项模型确定检测AA和CRC的PPV以及相对风险,并根据筛查史估计解剖亚部位的分布。
中位年龄为61岁(AA参与者为62岁,CRC参与者为64岁)。检测晚期肿瘤的PPV为24.5%,男性显著高于女性(30.7%对17.7%),且随年龄增加。在首次筛查后的所有筛查阶段PPV均下降。随后的筛查阶段与近端AA的风险增加相关(风险比RR 1.13,95%置信区间CI 1.16 - 1.20)。年龄增长(每增加10岁RR 1.28,95% CI 1.19 - 1.39)、女性性别(RR 1.31,95% CI 1.19 - 1.44)以及随后的筛查(RR 1.15,95% CI 1.04 - 1.27)与近端腺癌的检测显著且独立相关。后者在晚期也更常被检测到(RR,1.24,95% CI:1.09 - 1.42)。浸润性腺癌的早期阶段(I期和II期)在后续筛查中比初次筛查更易被检测到(RR 1.07,95% CI 1.01 - 1.13)。
本研究发现,使用g - FOBT进行后续筛查与近端AA和CRC的检出率增加相关,尤其是在女性中。在后续筛查中更频繁地检测到晚期近端浸润性腺癌表明,这些肿瘤中的一些很可能并非真正的新发病变,而是可能包括先前筛查中漏诊的病变。尽管增幅不大,但从初次筛查到后续筛查,早期(且更可治愈)阶段浸润性腺癌的检出率有所增加,同时初次筛查存在漏诊的可能性,以及后续筛查中近端或直肠AA的检出率增加,都强调了有必要加强民众对阴性结果后定期持续筛查重要性的认识。